Biotech Aromics obtains the seal ‘Innovative SME’ Blog Post

The Ministry of Economy and Competitiveness recently awarded the biotech Aromics the seal of ‘Pyme Innovadora‘ ( Innovative SME)The company -founded in 2005 and specialized in the application of omic sciences in the research and development of new drugs and diagnostic methods- was part of the first generation of companies that participated in the Bioincubator project at the Barcelona Science Park (PCB).

 

GreeNC, the first database of non-coding RNAs in plants Blog Post

Sequentia Biotech, a company based at the Barcelona Science Park (PCB), has developed the first database of non-coding RNAs in vegetal species: GreeNC. It is a repository of more than 200,000 lncRNAs annotated in 37 plant species and 6 algae that provides information about the sequence, genomic coordinates, coding potential, and folding energy for all lncRNAs identified. 

 

Jordi Naval: “I think both researchers and companies should expand their scope of vision and ask themselves where they are headed” Blog Post

Jordi Naval takes over the management of Fundació Bosch i Gimpera (FBG) with a clear objective: building a climate of trust and interaction among researchers, investors and the productive fabric. A very ambitious challenge that Naval faces with the skill and resolution that his double ‘expertise’ as both, a scientist and entrepreneur, has given him.

 

The 4th edition of the ‘Crazy about Biomedicine’ kicks off Blog Post

On Saturday, the 24 students chosen from more than 200 applicants for the ‘Crazy about Biomedicine course‘ at IRB Barcelona will have their first theory class in the centre, with the collaboration of the Barcelona Science Park (PCB). In fact, the success of first course in this field of science in 2013, an initiative of IRB Barcelona, led the Catalunya–La Pedrera Foundation to increase the number of disciplines on offer and to set up new courses, all of which fall under the umbrella of the ‘Crazy about Science Programme‘. 

 

Cells are liquids, but behave like solids Blog Post

Scientists at the Institute for Bioengineering of Catalonia (IBEC) at PCB have revealed that, counter to previous understanding, the living cells in our bodies behave like solids rather than the liquids they are made of. The finding changes the way we think about processes such as embryo development or wound healing. 

 

Doing your PhD at IBEC! Blog Post

The Institute for Bioengineering of Catalonia (IBEC) at PCB is looking for PhD candidates to apply for the International PhD Programme at IBEC from ”la Caixa”– Severo Ochoa fellowships, and ‘Ayudas para contratos predoctorales para la formación de doctores 2016’ fellowships funded by Ministry of Economy and Competitiveness (Mineco). Students selected will have the opportunity to start your research career in a stimulating, interdisciplinary and high quality international scientific environment.

 

IRB Barcelona researcher Benjamí Oller wins one of the ‘Premis Pioner 2015’ Blog Post

The young scientist Benjamí Oller, who recently defended his PhD thesis, done in Prof. Ernest Giralt’s lab at the Institute for Research in Biomedicine (IRB Barcelona), has been awarded one of the five ‘Premis Pioner 2015‘ (Pioneer Prizes 2015), which are presented by the CERCA Institute –an organisation belonging to the Government of Catalonia– in order to recognize to recent doctorates that orient his research to obtain industrial or commercial results. 
 

Ignasi Belda: “We are the only service provider in computational chemistry with a presence in five countries” Blog Post

Intelligent Pharma, specializing in computational chemistry services for the pharmaceutical and biotechnological industries, recently opened a new office in Munich (Germany). It is the fifth international office that the company has set up in the same number of years. The company also recently received a capital injection of 550,000 euros from the Avanza 2 program from the Spanish Ministry of Industry, Energy and Tourism, and the Torres Quevedo call from the Ministry of Economy and Competitiveness.

 

Scientists in Barcelona discover a potential treatment for cirrhosis Blog Post

Scientists from the Institute for Research in Biomedicine (IRB Barcelona) at PCB and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) reveals a therapeutic target to prevent the development of the many abnormal blood vessels that cause gastrointestinal bleeding—the main complication in cirrhosis. The results of the study have been published in the most recent issue of Cirrhosis is the main risk factor for liver cancer. The same target may be the key to preventing and treating this condition.